IWLA has been closely engaging the California Board of Pharmacy after issuance of AB 2605, a statewide pharmaceutical licensing requirement on third-party logistics providers.
IWLA members fully support licensing standards in order to keep the supply chain secure and to protect citizens’ health and safety. However, IWLA does not see a need for additional licensing in the state of California: This is not a necessity, given the federal licensing requirements outlined in title II of the Drug Supply Chain Security Act (DSCSA).
“To single out California’s drug supply chain from the rest of the country and impose overly burdensome licensing requirements is unreasonable. When federal and state requirements conflict, the most likely outcome is always more confusion, less compliance,” says IWLA President & CEO Steve DeHaan.
A letter sent to the California Senate Business, Professions, and Economic Development Committee, specifically asks for additional amendments to the current standards to align state requirements with federal requirements.
The letter is just one step in IWLA’s continued discussions with the California Board of Pharmacy. Stay tuned for more.